Cementoblastoma

WikiDoc Resources for Cementoblastoma
Articles
Most recent articles on Cementoblastoma Most cited articles on Cementoblastoma Review articles on Cementoblastoma Articles on Cementoblastoma in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Cementoblastoma Images of Cementoblastoma Photos of Cementoblastoma Podcasts & MP3s on Cementoblastoma Videos on Cementoblastoma
Evidence Based Medicine
Cochrane Collaboration on Cementoblastoma Bandolier on Cementoblastoma TRIP on Cementoblastoma
Clinical Trials
Ongoing Trials on Cementoblastoma at Clinical Trials.gov Trial results on Cementoblastoma Clinical Trials on Cementoblastoma at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Cementoblastoma NICE Guidance on Cementoblastoma NHS PRODIGY Guidance FDA on Cementoblastoma CDC on Cementoblastoma
Books
Books on Cementoblastoma
News
Cementoblastoma in the news Be alerted to news on Cementoblastoma News trends on Cementoblastoma
Commentary
Blogs on Cementoblastoma
Definitions
Definitions of Cementoblastoma
Patient Resources / Community
Patient resources on Cementoblastoma Discussion groups on Cementoblastoma Patient Handouts on Cementoblastoma Directions to Hospitals Treating Cementoblastoma Risk calculators and risk factors for Cementoblastoma
Healthcare Provider Resources
Symptoms of Cementoblastoma Causes & Risk Factors for Cementoblastoma Diagnostic studies for Cementoblastoma Treatment of Cementoblastoma
Continuing Medical Education (CME)
CME Programs on Cementoblastoma
International
Cementoblastoma en Espanol Cementoblastoma en Francais
Business
Cementoblastoma in the Marketplace Patents on Cementoblastoma
Experimental / Informatics
List of terms related to Cementoblastoma

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Maria Fernanda Villarreal, M.D. [2]

Synonyms and keywords: Synonym 1; Synonym 2; Synonym 3

Historical Perspective

• Cementoblastoma was first discovered by [scientist name], a [nationality + occupation], in [year] during/following [event].
• In [year], [gene] mutations were first identified in the pathogenesis of cementoblastoma.
• In [year], the first [discovery] was developed by [scientist] to treat/diagnose cementoblastoma.

Classification

• Cementoblastoma may be classified according to [classification method] into [number] subtypes/groups:

• [group1]
• [group2]
• [group3]

• Other variants of cementoblastoma include [disease subtype 1], [disease subtype 2], and [disease subtype 3].

Pathophysiology

• The pathogenesis of cementoblastoma is characterized by [feature1], [feature2], and [feature3].
• The [gene name] gene/Mutation in [gene name] has been associated with the development of cementoblastoma, involving the [molecular pathway] pathway.
• On gross pathology, [feature1], [feature2], and [feature3] are characteristic findings of cementoblastoma.
• On microscopic histopathological analysis, [feature1], [feature2], and [feature3] are characteristic findings of cementoblastoma.

Causes

• Cementoblastoma may be caused by either [cause1], [cause2], or [cause3].
• Cementoblastoma is caused by a mutation in the [gene1], [gene2], or [gene3] gene[s].
• There are no established causes for cementoblastoma.

Differentiating cementoblastoma from other Diseases

• Cementoblastoma must be differentiated from other diseases that cause [clinical feature 1], [clinical feature 2], and [clinical feature 3], such as:

• [Differential dx1]
• [Differential dx2]
• [Differential dx3]

Epidemiology and Demographics

• The prevalence of cementoblastoma is approximately [number or range] per 100,000 individuals worldwide.
• In [year], the incidence of cementoblastoma was estimated to be [number or range] cases per 100,000 individuals in [location].

Age

• Patients of all age groups may develop cementoblastoma.

• Cementoblastoma is more commonly observed among patients aged [age range] years old.
• Cementoblastoma is more commonly observed among [elderly patients/young patients/children].

Gender

• Cementoblastoma affects men and women equally.

• [Gender 1] are more commonly affected with cementoblastoma than [gender 2].
• The [gender 1] to [Gender 2] ratio is approximately [number > 1] to 1.

Race

• There is no racial predilection for cementoblastoma.

• Cementoblastoma usually affects individuals of the [race 1] race.
• [Race 2] individuals are less likely to develop cementoblastoma.

Risk Factors

• Common risk factors in the development of cementoblastoma are [risk factor 1], [risk factor 2], [risk factor 3], and [risk factor 4].

Natural History, Complications and Prognosis

• The majority of patients with cementoblastoma remain asymptomatic for [duration/years].
• Early clinical features include [manifestation 1], [manifestation 2], and [manifestation 3].
• If left untreated, [#%] of patients with cementoblastoma may progress to develop [manifestation 1], [manifestation 2], and [manifestation 3].
• Common complications of cementoblastoma include [complication 1], [complication 2], and [complication 3].
• Prognosis is generally [excellent/good/poor], and the [1/5/10­year mortality/survival rate] of patients with cementoblastoma is approximately [#%].

Diagnosis

Diagnostic Criteria

• The diagnosis of cementoblastoma is made when at least [number] of the following [number] diagnostic criteria are met:

• [criterion 1]
• [criterion 2]
• [criterion 3]
• [criterion 4]

Symptoms

• Cementoblastoma is usually asymptomatic.
• Symptoms of cementoblastoma may include the following:

• [symptom 1]
• [symptom 2]
• [symptom 3]
• [symptom 4]
• [symptom 5]
• [symptom 6]

Physical Examination

• Patients with cementoblastoma usually appear [general appearance].
• Physical examination may be remarkable for:

• [finding 1]
• [finding 2]
• [finding 3]
• [finding 4]
• [finding 5]
• [finding 6]

Laboratory Findings

• There are no specific laboratory findings associated with cementoblastoma.

• A [positive/negative] [test name] is diagnostic of cementoblastoma.
• An [elevated/reduced] concentration of [serum/blood/urinary/CSF/other] [lab test] is diagnostic of cementoblastoma.
• Other laboratory findings consistent with the diagnosis of cementoblastoma include [abnormal test 1], [abnormal test 2], and [abnormal test 3].

Imaging Findings

• There are no [imaging study] findings associated with cementoblastoma.

• [Imaging study 1] is the imaging modality of choice for cementoblastoma.
• On [imaging study 1], cementoblastoma is characterized by [finding 1], [finding 2], and [finding 3].
• [Imaging study 2] may demonstrate [finding 1], [finding 2], and [finding 3].

Other Diagnostic Studies

• Cementoblastoma may also be diagnosed using [diagnostic study name].
• Findings on [diagnostic study name] include [finding 1], [finding 2], and [finding 3].

Treatment

Medical Therapy

• There is no treatment for cementoblastoma; the mainstay of therapy is supportive care.

• The mainstay of therapy for cementoblastoma is [medical therapy 1] and [medical therapy 2].
• [Medical therapy 1] acts by [mechanism of action1].
• Response to [medical therapy 1] can be monitored with [test/physical finding/imaging] every [frequency/duration].

Surgery

• Surgery is the mainstay of therapy for cementoblastoma.
• [Surgical procedure] in conjunction with [chemotherapy/radiation] is the most common approach to the treatment of cementoblastoma.
• [Surgical procedure] can only be performed for patients with [disease stage] cementoblastoma.

Prevention

• There are no primary preventive measures available for cementoblastoma.

• Effective measures for the primary prevention of cementoblastoma include [measure1], [measure2], and [measure3].

• Once diagnosed and successfully treated, patients with cementoblastoma are followed-up every [duration]. Follow-up testing includes [test 1], [test 2], and [test 3].